Filing Details
Immuneering Corp (NASDAQ:IMRX) filed a Form 8-K with the Securities and Exchange Commission on August 05, 2026, disclosing a material event.
8k filedNASDAQ:IMRX
Immuneering Corp (IMRX) Reports Material Event to SEC
Filing Details Immuneering Corp (NASDAQ:IMRX) filed a Form 8-K with the Securities and Exchange Commission on August 05, 2026, disclosing a material event. Market Context…
Market Context
Immuneering Corp's stock currently trades at $4.39 with a market capitalization of $224.7M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Immuneering Corp's stock.
All SEC filings for Immuneering Corp are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IMRX Stock Page
Frequently Asked Questions
Where can I read IMRX's SEC filings?
Browse all filings on our IMRX SEC filings page.
What types of SEC filings does Immuneering Corp file?
Public companies like Immuneering Corp file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.